Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 387Neoplasms 333Prostatic Neoplasms 188Lung Neoplasms 175Colorectal Neoplasms 142Motor Activity 87Pancreatic Neoplasms 73Uterine Cervical Neoplasms 70Brain Neoplasms 69Head and Neck Neoplasms 67Carcinoma, Non-Small-Cell Lung 63Ovarian Neoplasms 59Rectal Neoplasms 49Carcinoma, Hepatocellular 49Colonic Neoplasms 46Glioblastoma 42Anxiety Disorders 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Depression 39Neoplasm Metastasis 38Hematologic Neoplasms 37Melanoma 34Glioma 34Multiple Myeloma 33Disease 33Stomach Neoplasms 32Sarcoma 31Carcinoma, Renal Cell 30Urinary Bladder Neoplasms 29Pain 28

Interventions

propranolol mustard 1Lasers, Solid-State 1Lasers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Hemangioma, Capillary × 90 days × Clear all
NCT07183644 2026-06-05

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

University of Texas Southwestern Medical Center

Phase NA Recruiting
200 enrolled

Hemangioma, Capillary, Port-Wine Stain

NCT07560332 2026-05-01

Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma

Cairo University

Phase NA Completed
30 enrolled

Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡